
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-12-19YCBDSCHEDULE 13G/ACBDMD, INC. - SCHEDULE 13G/A Filing AmendmentMEDIUM
This filing is an amendment to a Schedule 13G, reporting a change in beneficial ownership of CBDMD, INC. common shares. The filing is made jointly by CRC Investment Fund LP, NM 2018 Trust, AMC Legacy Trust, and Clark R. Crosnoe. As of November 6, 2025, the total number of outstanding common shares was 8,919,410. Clark ...
Nano CapDrug Manufacturers - Specialty & Generic
2025-12-19TZUPSCHEDULE 13G/AForm 13G Filing for Datacentrex, Inc.MEDIUM
This filing details Joe Thomas's beneficial ownership of Datacentrex, Inc. common stock. As of December 19, 2025, Joe Thomas, through entities SLS Group LLC and Classic Solutions Corp, beneficially owns 864,106 shares, representing 2.9% of the class. This ownership is held with sole voting and dispositive power. The fi...
ownership +2.90%
2025-12-19ERNASCHEDULE 13G/AAmendment No. 5 to Schedule 13G for Ernexa Therapeutics Inc.MEDIUM
This filing details an amendment to Schedule 13G for Ernexa Therapeutics Inc. (formerly Eterna Therapeutics, Inc.), reporting changes in beneficial ownership. The reporting persons are Freebird Partners LP, Freebird Investments LLC, and Curtis W. Huff. Freebird Investments LLC acts as the general partner of Freebird Pa...
Nano CapBiotechnologyownership +9.90%
2025-12-19Ernexa Therapeutics Inc.SCHEDULE 13G/AAmendment No. 5 to Schedule 13G for Ernexa Therapeutics Inc.DuplicateMEDIUM
This filing details an amendment to Schedule 13G for Ernexa Therapeutics Inc. (formerly Eterna Therapeutics, Inc.), reporting changes in beneficial ownership. The reporting persons are Freebird Partners LP, Freebird Investments LLC, and Curtis W. Huff. Freebird Investments LLC acts as the general partner of Freebird Pa...
Nano CapBiotechnologyownership +9.90%
2025-12-19GTESCHEDULE 13G/AGRAN TIERRA ENERGY INC. - SCHEDULE 13G/A Filing AmendmentHIGH
This filing is an amendment to a Schedule 13G for GRAN TIERRA ENERGY INC. The filing details the beneficial ownership of Common Stock by Daniel Lau, Christine Man, LM Asset (IM) Inc., LM Asset Fund Limited Partnership, and LM Asset Management Inc. Daniel Lau holds 11.5% (4,056,200 shares), Christine Man holds 11.0% (3,...
Micro CapOil & Gas E&P
2025-12-19SHCSCHEDULE 13G/AGTCR Entities Amend Schedule 13G for Sotera Health Co. HoldingsMEDIUM
This filing is an amendment (No. 5) to Schedule 13G, jointly filed by GTCR Investment XI LLC and its affiliated entities (collectively, "GTCR Reporting Persons"). The filing concerns Sotera Health Co. ("Issuer") and reports beneficial ownership of the Issuer's common stock. As of October 28, 2025, the GTCR Reporting Pe...
Mid CapDiagnostics & Researchownership +20.00%
2025-12-19GRAN TIERRA ENERGY INC.SCHEDULE 13G/AGRAN TIERRA ENERGY INC. - SCHEDULE 13G/A Filing AmendmentDuplicateHIGH
This filing is an amendment to a Schedule 13G for GRAN TIERRA ENERGY INC. The filing details the beneficial ownership of Common Stock by Daniel Lau, Christine Man, LM Asset (IM) Inc., LM Asset Fund Limited Partnership, and LM Asset Management Inc. Daniel Lau holds 11.5% (4,056,200 shares), Christine Man holds 11.0% (3,...
Micro CapOil & Gas E&P
Sponsored
2025-12-19BRTXSCHEDULE 13G/AMorrison Todd Hale Increases Stake in BioRestorative Therapies, Inc. to 7.7%MEDIUM
Todd Hale Morrison, a significant shareholder, has increased their beneficial ownership in BioRestorative Therapies, Inc. to 7.7% of the outstanding common stock. This change is based on the acquisition of 685,000 shares, bringing the total to this percentage as of December 18, 2025. The previous ownership was 0%. This...
Nano CapBiotechnologyownership +7.70%
2025-12-19RSFSCHEDULE 13G/ACSS LLC/IL Increases Stake in RiverNorth Capital & Income Fund, Inc. to 6.27%MEDIUM
CSS LLC/IL, an Illinois-based entity, has increased its beneficial ownership in RiverNorth Capital & Income Fund, Inc. to 266,670 shares, representing 6.27% of the common stock. This filing, an amendment (No. 3) to a SCHEDULE 13G, indicates that the acquisition was not made for the purpose of influencing the control of...
ownership +6.27%
2025-12-19GTCR INVESTMENT XI LLCSCHEDULE 13G/AGTCR Entities Amend Schedule 13G for Sotera Health Co. HoldingsDuplicateMEDIUM
This filing is an amendment (No. 5) to Schedule 13G, jointly filed by GTCR Investment XI LLC and its affiliated entities (collectively, "GTCR Reporting Persons"). The filing concerns Sotera Health Co. ("Issuer") and reports beneficial ownership of the Issuer's common stock. As of October 28, 2025, the GTCR Reporting Pe...
Mid CapDiagnostics & Researchownership +20.00%
2025-12-19Datacentrex, Inc.SCHEDULE 13G/AForm 13G Filing for Datacentrex, Inc.DuplicateMEDIUM
This filing details Joe Thomas's beneficial ownership of Datacentrex, Inc. common stock. As of December 19, 2025, Joe Thomas, through entities SLS Group LLC and Classic Solutions Corp, beneficially owns 864,106 shares, representing 2.9% of the class. This ownership is held with sole voting and dispositive power. The fi...
ownership +2.90%
2025-12-19VISTSCHEDULE 13G/AAl Mehwar & ADIC File 13G/A for Vista EnergyMEDIUM
This filing reports that Al Mehwar Commercial Investments LLC ("Al Mehwar") and Abu Dhabi Investment Council Company P.J.S.C. ("ADIC") collectively hold 13,270,363 shares of Vista Energy, S.A.B. de C.V. This represents 12.7% of the outstanding Series A Shares, based on 104,256,410 shares reported as of August 27, 2025....
Mid CapOil & Gas E&Pownership +12.70%
2025-12-19Crosnoe Clark R.SCHEDULE 13G/ACBDMD, INC. - SCHEDULE 13G/A Filing AmendmentDuplicateMEDIUM
This filing is an amendment to a Schedule 13G, reporting a change in beneficial ownership of CBDMD, INC. common shares. The filing is made jointly by CRC Investment Fund LP, NM 2018 Trust, AMC Legacy Trust, and Clark R. Crosnoe. As of November 6, 2025, the total number of outstanding common shares was 8,919,410. Clark ...
Nano CapDrug Manufacturers - Specialty & Generic